SecBot SecBot
8-K ·Filed Apr 21, 2026

PULM

Pulmatrix, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed6mo ago SEC0001493152-26-018202
8-K context-dependent: Items 7.01, 8.01
Actionable Insight • Neutral

Monitor upcoming filings for further details on the merger with Eos SENOLYTIX and any additional capital raises, as the $1 million raise is modest for a biotech company and may indicate ongoing funding challenges.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$1.38
T+0 close · Apr 21, 2026 · via day close
Latest settled
+16.67%
T+60 · $1.61
Vs SPY
+9.77%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $1.38entry
  2. T+1 · 7mo ago +1.45%α +0.43% · $1.40
  3. T+5 · 7mo ago −7.25%α −8.33% · $1.28
  4. T+20 · 6mo ago −8.70%α −13.61% · $1.26
  5. T+60 · 4mo ago +16.67%α +9.77% · $1.61
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Pulmatrix, Inc. closed a $1 million private placement of Series B Preferred Stock with an affiliate of Eos SENOLYTIX, Inc. as part of its planned merger. The preferred shares are convertible into common stock at $2.20 per share and carry voting rights.

Key Facts

  • Pulmatrix closed a private placement of Series B Preferred Stock on April 16, 2026
  • The offering raised approximately $1 million in gross proceeds
  • The investment was made by an affiliate of Eos SENOLYTIX, Inc.
  • The Series B Preferred Stock is convertible into common stock at $2.20 per share
  • The transaction is part of a planned merger between Pulmatrix and Eos
  • Proceeds will be used for working capital and general corporate purposes

Financial Impact

Approximately $1 million in gross proceeds from the private placement

cashdilutionequity

Risk Factors

  • The small size of the financing ($1 million) may not be sufficient to sustain operations long-term
  • Potential dilution to existing shareholders upon conversion of preferred shares
  • Uncertainty around the completion of the planned merger with Eos SENOLYTIX

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-018202
Exhibit: ex99-1.htm0001493152-26-018202
Document: 0001493152-26-018202-index-headers.html0001493152-26-018202
Document: 0001493152-26-018202-index.html0001493152-26-018202
Document: 0001493152-26-018202.txt0001493152-26-018202

Track record

21 reports on PULM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +15.29% at T+60 after the Aug 7, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 9, 20267d ago 425 Neutral 3/10 Entry $1.36 to $1.33 Now $1.33 −1.85% ▼ −1.84% −0.15% vs SPY
  2. Oct 30, 202617d ago 425 Neutral 3/10 Entry $1.40 to $1.38 Now $1.33 −5.00% ▼ −1.43% +1.27% vs SPY
  3. Oct 23, 202625d ago EFFECT Bearish 5/10 Entry $1.48 to $1.40 Now $1.33 +10.14% ▲ +5.41% +4.85% vs SPY
  4. Oct 22, 202625d ago 425 Neutral 4/10 Entry $1.42 to $1.41 Now $1.33 −6.34% ▼ −0.70% −1.41% vs SPY
  5. Oct 13, 20264w ago 425 Neutral 4/10 Entry $1.38 to $1.43 Now $1.33 −3.62% ▲ +3.62% +4.77% vs SPY
  6. Oct 7, 20265w ago DEFA14A Neutral 2/10 Entry $1.53 to $1.41 Now $1.33 −12.91% ▼ −7.67% −7.39% vs SPY
  7. Oct 2, 20266w ago S-3/A Bearish 5/10 Entry $1.48 to $1.43 Now $1.33 +10.14% ▲ +3.38% +3.80% vs SPY
  8. Sep 28, 20267w ago EFFECT Bearish 5/10 Entry $1.59 to $1.48 Now $1.33 +16.35% ▲ +6.92% +8.12% vs SPY
  9. Sep 25, 20267w ago DEFM14A Bearish 6/10 Entry $1.59 to $1.48 Now $1.33 +16.35% ▲ +6.92% +8.12% vs SPY
  10. Sep 23, 20267w ago S-4/A Neutral 2/10 Entry $1.67 to $1.54 Now $1.33 −20.36% ▼ −7.78% −7.37% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026